423 related articles for article (PubMed ID: 15050686)
1. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
[TBL] [Abstract][Full Text] [Related]
2. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
3. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
Hasegawa M
Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
[TBL] [Abstract][Full Text] [Related]
4. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic neuropathology of tauopathy].
Murayama S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1101-3. PubMed ID: 12235808
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
7. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
[TBL] [Abstract][Full Text] [Related]
8. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
9. Pick's complex and FTDP-17.
Kertesz A
Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
[TBL] [Abstract][Full Text] [Related]
10. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies.
Hanes J; Zilka N; Bartkova M; Caletkova M; Dobrota D; Novak M
J Neurochem; 2009 Mar; 108(5):1167-76. PubMed ID: 19141083
[TBL] [Abstract][Full Text] [Related]
11. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
12. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
13. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
14. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
15. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
[TBL] [Abstract][Full Text] [Related]
16. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
[TBL] [Abstract][Full Text] [Related]
17. Atypical progressive supranuclear palsy with corticospinal tract degeneration.
Josephs KA; Katsuse O; Beccano-Kelly DA; Lin WL; Uitti RJ; Fujino Y; Boeve BF; Hutton ML; Baker MC; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):396-405. PubMed ID: 16691120
[TBL] [Abstract][Full Text] [Related]
18. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of the tauopathies.
Murray B; Lynch T; Farrell M
Biochem Soc Trans; 2005 Aug; 33(Pt 4):595-9. PubMed ID: 16042552
[TBL] [Abstract][Full Text] [Related]
20. Tau gene mutations and their effects.
Goedert M
Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
